CLNN (STOCKS)
Clene Inc. Common Stock
$4.130000
-0.290000 (-6.56%)
Prev close: $4.420000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert Dee Etherington
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49.75M
- Employees
- 76
- P/E (TTM)
- -1.30
- P/B (TTM)
- -3.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.85 | $-0.59 | -0.2584 | -43.68% |
|
Jun 2025 (Q2)
|
$-0.78 | $-0.48 | -0.2972 | -61.56% |
|
Mar 2025 (Q1)
|
$-0.09 | $-0.97 | +0.8790 | +90.71% |
|
Dec 2024 (Q4)
|
$-1.86 | $-0.97 | -0.8910 | -91.95% |
Financial Statements
| Revenues | $214.00K |
| Benefits Costs and Expenses | $30.71M |
| Cost Of Revenue | $38.00K |
| Costs And Expenses | $24.46M |
| Gross Profit | $176.00K |
| Nonoperating Income/Loss | -$6.25M |
| Operating Expenses | $24.42M |
| Research and Development | $14.08M |
| Other Operating Expenses | $10.34M |
| Operating Income/Loss | -$24.24M |
| Income/Loss From Continuing Operations After Tax | -$30.50M |
| Income/Loss From Continuing Operations Before Tax | -$30.50M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$30.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$30.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$30.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.44 |
| Basic Average Shares | 10,036,023 |
| Assets | $22.31M |
| Current Assets | $12.67M |
| Cash | $7.90M |
| Inventory | $61.00K |
| Other Current Assets | $4.71M |
| Noncurrent Assets | $9.64M |
| Liabilities | $34.67M |
| Current Liabilities | $8.31M |
| Accounts Payable | $1.37M |
| Other Current Liabilities | $6.94M |
| Noncurrent Liabilities | $26.36M |
| Long-term Debt | $17.88M |
| Other Non-current Liabilities | $8.49M |
| Equity | -$12.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$12.36M |
| Liabilities And Equity | $22.31M |
| Net Cash Flow From Operating Activities | -$18.61M |
| Net Cash Flow From Operating Activities, Continuing | -$18.61M |
| Net Cash Flow From Investing Activities | -$13.00K |
| Net Cash Flow From Investing Activities, Continuing | -$13.00K |
| Net Cash Flow From Financing Activities | $11.98M |
| Net Cash Flow From Financing Activities, Continuing | $11.98M |
| Net Cash Flow | -$6.65M |
| Net Cash Flow, Continuing | -$6.65M |
| Comprehensive Income/Loss | -$30.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.57M |
| Other Comprehensive Income/Loss | -$22.48M |
| Other Comprehensive Income/Loss Attributable To Parent | -$73.00K |